Mucoadhesive nano-sized supramolecular assemblies for improved pre-corneal drug residence time

References

• Chrai SS, Robinson JR. Ocular evaluation of methylcellulose vehicle in albino rabbits. J Pharm Sci 1974;63:1218–23
   PubMed Web of Science ®Google Scholar
• Lee VHL, Robinson JR. Review: topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol 1986;2:67–108
   PubMedGoogle Scholar
• Patton TF, Robinson JR. Ocular evaluation of polyvinylalcohol vehicle in rabbits. J Pharm Sci 1975;64:1312–16
   PubMed Web of Science ®Google Scholar
• Saettone MF, Giannaccini B, Ravecca S, et al. Polymer effects on ocular bioavailability – the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and rabbits. Int J Pharm 1984;20:187–202
   Web of Science ®Google Scholar
• Saettone MF, Giannaccini B, Teneggi A, et al. Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man. J Pharm Pharmacol 1982;34:464–6
   PubMed Web of Science ®Google Scholar
• Trueblood JH, Rossomondo RM, Wilson LA, Carlton WH. Corneal contact times of ophthalmic vehicles. Evaluation by microscintigraphy. Archiv Ophthalmol 1975;93:127–30
   PubMed Web of Science ®Google Scholar
• Lihong W, Xin C, Yongxue G, et al. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro–in vivo evaluation. Drug Dev Ind Pharm 2014;40:1402–10
   PubMed Web of Science ®Google Scholar
• Pathak MK, Chhabra G, Pathak K. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm 2013;39:780–90
   PubMed Web of Science ®Google Scholar
• Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013;39:1599–617
   PubMed Web of Science ®Google Scholar
• Hui H-W, Robinson JR. Ocular drug delivery of progesterone using a bioadhesive polymer. Int J Pharm 1985;26:203–13
   Web of Science ®Google Scholar
• Di Colo G, Zambito Y, Zaino C, Sansò M. Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model. Drug Dev Ind Pharm 2009;35:941–9
   PubMed Web of Science ®Google Scholar
• Uccello-Barretta G, Nazzi S, Zambito Y, et al. Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops. Int J Pharm 2010;395:122–31
   PubMed Web of Science ®Google Scholar
• Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477–80
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobão P, et al. Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations. J Pharm Pharm Sci 2014;17:278–93
   PubMed Web of Science ®Google Scholar
• Singh J, Chhabra G, Pathak K. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro, ex vivo evaluation and pharmacodynamic study. Drug Dev Ind Pharm 2014;40:1223–32
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobão P, et al. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today 2014;19:400–12
   PubMed Web of Science ®Google Scholar
• Zambito Y, Di Colo G. Thiolated quaternary ammonium–chitosan conjugates for enhanced precorneal retention, transcorneal permeation and intraocular absorption of dexamethasone. Eur J Pharm Biopharm 2010;75:194–9
   PubMed Web of Science ®Google Scholar
• Ameeduzzafar Ali J, Bhatnagar A, et al. Chitosan nanoparticles amplify the ocular hypotensive effect of carteolol in rabbits. Int J Biol Macromol 2014;5:479–91
   Web of Science ®Google Scholar
• Akhter S, Ramazani F, Ahmad MZ, et al. Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits. Eur J Nanomed 2013;5:159–67
   Google Scholar
• Zambito Y, Felice F, Fabiano A, et al. Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan. Carbohydr Polym 2013;92:33–9
   PubMed Web of Science ®Google Scholar
• Janes KA, Alonso MJ. Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization. J Appl Polym Sci 2003;88:2769–76
   Web of Science ®Google Scholar
• Mao S, Shuai X, Unger F, et al. The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm 2004;281:45–54
   PubMed Web of Science ®Google Scholar
• Shu XZ, Liu Y, Luo Y, et al. Disulfide crosslinked hyaluronan hydrogels. Biomacromolecules 2002;3:1304–11
   PubMed Web of Science ®Google Scholar
• Kashi SD, Lee VHL. Hydrolisis of enkephalins in homogenates of anterior segment tissues of the albino rabbit eye. Invest Ophthalmol Visual Sci 1986;27:1300–3
   PubMed Web of Science ®Google Scholar
• Hämäläinen KM, Ranta VP, Auriola S, Urtti A. Enzymatic and permeation barrier of [d-Ala2]-Met-enkephalinamide in the anterior membranes of the albino rabbit eye. Eur J Pharm Sci 2000;9:265–70
   PubMed Web of Science ®Google Scholar
• Drago F, Panissidi G, Bellomio F, et al. Effects of opiates and opioids on intraocular pressure of rabbits and humans. Clin Exp Pharmacol Physiol 1985;12:107–13
   PubMed Web of Science ®Google Scholar
• Greaves JL, Wilson CG. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv Drug Deliv Rev 1993;11:349–83
   Web of Science ®Google Scholar
• Saettone MF, Giannaccini B, Barattini F, Tellini N. The validity of rabbits for investigations on ophthalmic vehicles: a comparison of four different vehicles containing tropicamide in humans and rabbits. Pharm Acta Helv 1982;57:47–55
   PubMedGoogle Scholar
• Zaki I, Fitzgerald P, Hardy JG, Wilson CG. A comparison of the effects of viscosity on the precorneal residence of solutions in rabbit and man. J Pharm Pharmacol 1986;38:463–6
   PubMed Web of Science ®Google Scholar
• Uccello-Barretta G, Nazzi S, Balzano F, et al. Enhanced affinity of ketotifen toward tamarind seed polysaccharide in comparison with hydroxyethylcellulose and hyaluronic acid: a nuclear magnetic resonance investigation. Bioorg Med Chem 2008;16:7371–6
   PubMed Web of Science ®Google Scholar
• Tamba BI, Dondas A, Leon M, et al. Silica nanoparticles: preparation, characterization and in vitro/in vivo biodistribution studies. Eur J Pharm Sci 2015;71:46–55
   PubMed Web of Science ®Google Scholar
• Khan MS, Vishakante GD, Bathool A. Development and characterization of pilocarpine loaded eudragit nanosuspensions for ocular drug delivery. J Biomed Nanotechnol 2013;9:124–31
   PubMed Web of Science ®Google Scholar
• Singh KH, Shinde UA. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane. Pharmazie 2011;66:594–9
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B: Biointerfaces 2010;81:412–21
   PubMed Web of Science ®Google Scholar
• Zambito Y, Pedreschi E, Di Colo G. Is dialysis a reliable method for studying drug release from nanoparticulate systems? – a case study. Int J Pharm 2012;434:28–34
   PubMed Web of Science ®Google Scholar
• Uccello-Barretta G, Balzano F, Aiello F, et al. Mucoadhesivity and release properties of quaternary ammonium–chitosan conjugates and their nanoparticulate supramolecular aggregates: an NMR investigation. Int J Pharm 2014;461:489–94
   PubMed Web of Science ®Google Scholar